Clinical characteristics and risk factors of colistin-induced nephrotoxicity
- 2 September 2009
- journal article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 34 (5), 434-438
- https://doi.org/10.1016/j.ijantimicag.2009.06.028
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Polymyxins RevisitedClinical Microbiology Reviews, 2008
- The Rationale for Developing Scoring Systems for Clinical PracticeThoracic Surgery Clinics, 2007
- Incidence and Outcomes in Acute Kidney InjuryJournal of the American Society of Nephrology, 2007
- Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICUInternational Journal of Antimicrobial Agents, 2006
- Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Toxicity of polymyxins: a systematic review of the evidence from old and recent studiesCritical Care, 2006
- Nephrotoxicity of intravenous colistin: a prospective evaluationInternational Journal of Antimicrobial Agents, 2005
- Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2005
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005
- Polymyxin and Related Peptide AntibioticsAnnual Review of Biochemistry, 1977